USE OF NOVEL PATIENT-DERIVED XENOGRAFTS AND MOLECULAR SUBTYPING TO IMPROVE PRECISION MEDICINE IN HIGH-GRADE SEROUS OVARIAN CANCER

被引：0

作者：

Heong, V. ^{[1
,2
,3
]}

Topp, M. ^{[1
,4
]}

Rutkowski, R. ^{[1
]}

Ananda, S. ^{[2
,5
]}

Wong, S. ^{[5
]}

Swisher, E. ^{[6
]}

Lindeman, G. ^{[1
]}

Haber, M. ^{[7
]}

Norris, M. D. ^{[7
]}

Haluska, P. ^{[8
]}

Wakefield, M. ^{[1
,3
]}

Bowtell, D. ^{[9
]}

Scott, C. L. ^{[1
,2
,3
]}

Lindeman, G. ^{[1
]}

机构：

[1] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia

[2] Royal Womens Hosp, Melbourne, Vic, Australia

[3] Univ Melbourne, Melbourne, Vic, Australia

[4] Monash Univ, Melbourne, Vic 3004, Australia

[5] Western Hosp, Footscray, Vic, Australia

[6] Univ Washington, Seattle, WA 98195 USA

[7] Childrens Canc Inst Australia, Sydney, NSW, Australia

[8] Mayo Clin, Rochester, MN USA

[9] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

来源：

关键词：

D O I：

10.1016/j.ejca.2014.03.042

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

OP0024

引用

页码：E9 / E9

页数：1